In this issue:
MRD assessment by MFC and NGF are biologically and prognostically concordant
Confirmation of validity of the standardised FDG PET negativity criteria
Fractionated dosing of humanised CAR T-cell therapy ARI0002h efficacious for RRMM
GSI augments CAR T-cell therapy
CARTITUDE-4: Cilta-cel bests standard triplets in lenalidomide-refractory MM
Response adaptive salvage with KTd and ASCT for functional high-risk MM
Cardiac events after ide-cel CAR T-cell therapy
Incidence and management of CRS with teclistamab in MajesTEC-1
Ide-cel effective after prior BCMA-targeted therapy
Concomitant del(1p13.3) and 1q21+ are associated with a poor clinical outcome
Please login below to download this issue (PDF)